| __timestamp | ADMA Biologics, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 242549000 |
| Thursday, January 1, 2015 | 7015946 | 245098000 |
| Friday, January 1, 2016 | 7688238 | 147600000 |
| Sunday, January 1, 2017 | 6229587 | 264600000 |
| Monday, January 1, 2018 | 3926120 | 357900000 |
| Tuesday, January 1, 2019 | 2343848 | 1182600000 |
| Wednesday, January 1, 2020 | 5907013 | 357700000 |
| Friday, January 1, 2021 | 3646060 | 540100000 |
| Saturday, January 1, 2022 | 3613764 | 322900000 |
| Sunday, January 1, 2023 | 3300000 | 408000000 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, United Therapeutics Corporation and ADMA Biologics, Inc. have demonstrated contrasting approaches to R&D investment.
United Therapeutics has consistently allocated a significant portion of its resources to R&D, with expenditures peaking in 2019 at over 1.18 billion dollars. This represents a staggering 388% increase from its 2016 low. In contrast, ADMA Biologics has maintained a more modest R&D budget, with a peak in 2014 and a gradual decline to 3.3 million dollars by 2023, a reduction of approximately 65% over the period.
These trends highlight the strategic differences between the two companies, with United Therapeutics focusing heavily on innovation, while ADMA Biologics adopts a more conservative approach.
Zoetis Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
R&D Spending Showdown: BeiGene, Ltd. vs ADMA Biologics, Inc.
United Therapeutics Corporation vs Exelixis, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: United Therapeutics Corporation vs Xenon Pharmaceuticals Inc.
United Therapeutics Corporation vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Veracyte, Inc.
Dr. Reddy's Laboratories Limited or ADMA Biologics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Blueprint Medicines Corporation vs ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and ADMA Biologics, Inc.
ADMA Biologics, Inc. vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
ADMA Biologics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending